Detalhe da pesquisa
1.
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.
Gastric Cancer
; 27(3): 558-570, 2024 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38308771
2.
Clinically conserved genomic subtypes of gastric adenocarcinoma.
Mol Cancer
; 22(1): 147, 2023 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37674200
3.
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
Oncology (Williston Park)
; 37(4): 176-183, 2023 04 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37104758
4.
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study.
Lancet Oncol
; 23(11): 1430-1440, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-36244398
5.
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 23(2): 234-247, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35030335
6.
Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study.
Gastric Cancer
; 25(1): 170-179, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34476643
7.
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
Gastric Cancer
; 25(1): 207-217, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34480657
8.
Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study.
Gastric Cancer
; 25(6): 1039-1049, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35920999
9.
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer.
Oncologist
; 26(3): e414-e424, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33274542
10.
Radiation-induced IL-1ß expression and secretion promote cancer cell migration/invasion via activation of the NF-κB-RIP1 pathway.
Biochem Biophys Res Commun
; 534: 973-979, 2021 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33176910
11.
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.
Gastric Cancer
; 24(4): 946-958, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33743112
12.
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 21(8): 1045-1056, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32682457
13.
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Lancet Oncol
; 21(8): 1066-1076, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32653053
14.
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer.
Gastric Cancer
; 23(1): 143-153, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31087200
15.
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
Gastric Cancer
; 23(3): 510-519, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31863227
16.
Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5.
J Cell Biochem
; 120(1): 928-939, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30160785
17.
A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First-line Therapy (KCSG ST10-01).
Oncologist
; 24(1): 18-e24, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30126861
18.
Codium fragile F2 sensitize colorectal cancer cells to TRAIL-induced apoptosis via c-FLIP ubiquitination.
Biochem Biophys Res Commun
; 508(1): 1-8, 2019 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30409427
19.
Genipin induces mitochondrial dysfunction and apoptosis via downregulation of Stat3/mcl-1 pathway in gastric cancer.
BMC Cancer
; 19(1): 739, 2019 Jul 27.
Artigo
Inglês
| MEDLINE | ID: mdl-31351462
20.
Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.
EMBO Rep
; 18(1): 150-168, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27993939